News

The clinical trial, named MERLIN TIMI-36, is designed to evaluate the efficacy and safety of Ranexa during acute and long-term treatment in approximately 6,500 patients with non-ST elevation

On March 24, 2006, Encysive received an approvable letter from the FDA regarding the company’s new drug application (NDA) for Thelin (sitaxsentan sodium) 100mg. The FDA is currently

The trial specifically evaluated the effect of the drug combination in treatment of hepatitis C patients with early cirrhosis of the liver who failed prior therapy. Addition of

Under the expanded collaboration, Seattle Genetics will develop and optimize certain methods suitable for manufacturing and testing PSMA ADC to support studies in humans. The new agreement is

In addition to the one-time, upfront payment, UCB will also receive royalties for a period of five years based on sales and a standard manufacturing supply agreement with

The BioMerieux coagulation product line comprises a comprehensive portfolio of diagnostic tests and a complete range of automated instruments. Trinity will pay $40 million on closing, together with

HER2-positive breast cancer, which affects approximately 20% to 30% of women with breast cancer, demands special and immediate attention because the tumors are fast-growing and there is a

The information can be found in the GSK Clinical Trial Register (CTR), a database accessible through the home page of the company's website. “We have created a record

The functioning assessment was part of a larger trial, of which the primary endpoint was to examine the ability of atomoxetine, the active ingredient in Strattera, to treat